Despite concerns over potential election disruptions, the presidential election unfolded with minimal interference, marking a ...

NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...

Adyen reported a strong third quarter with net revenue growth of 20% year-over-year, driven by expanding customer ...

(IN BRIEF) SUSS has reported strong Q3 results, with sales of €102.5 million and a 16.9% EBIT margin, continuing a robust ...